These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10761952)

  • 21. Reconsidering combined antiplatelet and anticoagulant therapy in atrial fibrillation.
    Falk RH
    J Am Coll Cardiol; 2004 Oct; 44(8):1567-9. PubMed ID: 15489086
    [No Abstract]   [Full Text] [Related]  

  • 22. ARISTOTLE expands the list of novel anticoagulants for thromboprophylaxis in atrial fibrillation.
    Tzeis S; Andrikopoulos G
    Angiology; 2012 Oct; 63(7):558-9. PubMed ID: 22669951
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of Bleeding Risk Scores in Patients With Nonvalvular Atrial Fibrillation Starting Direct Oral Anticoagulants.
    Caro Martínez C; Andreu Cayuelas JM; Flores Blanco PJ; Valdés M; Bailén Lorenzo JL; Manzano Fernández S
    Rev Esp Cardiol (Engl Ed); 2017 Oct; 70(10):878-880. PubMed ID: 28238647
    [No Abstract]   [Full Text] [Related]  

  • 24. Anticoagulation in elderly persons: a call for wider use.
    Portnoi VA
    Am Fam Physician; 1998 Jul; 58(1):39-40, 42. PubMed ID: 9672428
    [No Abstract]   [Full Text] [Related]  

  • 25. Rethinking warfarin for atrial fibrillation.
    Med Lett Drugs Ther; 2013 Sep; 55(1426):77. PubMed ID: 24081386
    [No Abstract]   [Full Text] [Related]  

  • 26. Non-vitamin K antagonist oral anticoagulants compared with warfarin at different levels of INR control in atrial fibrillation: A meta-analysis of randomized trials.
    Carmo J; Ferreira J; Costa F; Carmo P; Cavaco D; Carvalho S; Morgado F; Adragão P; Mendes M
    Int J Cardiol; 2017 Oct; 244():196-201. PubMed ID: 28679480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pro: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
    Healey JS
    Thromb Haemost; 2009 Nov; 102(5):912-3. PubMed ID: 19888528
    [No Abstract]   [Full Text] [Related]  

  • 28. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation.
    Gulløv AL; Koefoed BG; Petersen P
    Arch Intern Med; 1999 Jun; 159(12):1322-8. PubMed ID: 10386508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The efficiency and safety of anticoagulation therapy in atrial fibrillation in Chinese].
    Sun YH; Hu DY
    Zhonghua Nei Ke Za Zhi; 2004 Apr; 43(4):258-60. PubMed ID: 15130407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost effectiveness of novel oral anticoagulants for stroke prevention in atrial fibrillation depending on the quality of warfarin anticoagulation control.
    Janzic A; Kos M
    Pharmacoeconomics; 2015 Apr; 33(4):395-408. PubMed ID: 25512096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of ischemic stroke and hemorrhagic complications in warfarinized patients with non-valvular atrial fibrillation.
    Uchiyama S
    Intern Med; 2001 Dec; 40(12):1166-7. PubMed ID: 11813834
    [No Abstract]   [Full Text] [Related]  

  • 32. Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study.
    Gulløv AL; Koefoed BG; Petersen P; Pedersen TS; Andersen ED; Godtfredsen J; Boysen G
    Arch Intern Med; 1998 Jul; 158(14):1513-21. PubMed ID: 9679792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study.
    Buller HR; Halperin J; Hankey GJ; Pillion G; Prins MH; Raskob GE
    J Thromb Haemost; 2014 Jun; 12(6):824-30. PubMed ID: 24597472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pilot study of a novel patient self-management program for warfarin therapy using venipuncture-acquired international normalized ratio monitoring.
    Simmons BJ; Jenner KM; Delate T; Clark NP; Kurz D; Witt DM
    Pharmacotherapy; 2012 Dec; 32(12):1078-84. PubMed ID: 23112110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Warfarin therapy: evolving strategies in anticoagulation.
    Horton JD; Bushwick BM
    Am Fam Physician; 1999 Feb; 59(3):635-46. PubMed ID: 10029789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. South Africa's poor warfarin control raises questions of benefit above other anticoagulant therapies in atrial fibrillation.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(4):220. PubMed ID: 21881695
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Con.
    Keskar V; Sood MM
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):2085-2092. PubMed ID: 27797891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis of efficacy and safety of the new anticoagulants versus warfarin in patients with atrial fibrillation.
    Jia B; Lynn HS; Rong F; Zhang W
    J Cardiovasc Pharmacol; 2014 Oct; 64(4):368-74. PubMed ID: 24869601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the impact of warfarin time in therapeutic range on outcomes of patients with atrial fibrillation in Turkey: perspectives from the observational, prospective WATER Registry.
    Turk UO; Tuncer E; Alioglu E; Yuksel K; Pekel N; Ozpelit E; Vuran O; Tengiz I
    Cardiol J; 2015; 22(5):567-75. PubMed ID: 26100825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attack.
    Kamel H; Johnston SC; Easton JD; Kim AS
    Stroke; 2012 Mar; 43(3):881-3. PubMed ID: 22308255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.